Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Atenafu · SciRah

Researcher profile · Semantic Scholar

E. Atenafu

Share profile

E. Atenafu — researcher profile on SciRah

h-index: 53
Works: 491
Citations: 10K

Most-cited papers

Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay
M. Elliott, Philippe Echelard, C. Pipinikas, S. Main +15 more
2025Nature Communications44 citations Open access
Semantic Scholar
Cognitive Symptoms Across Diverse Cancers
Samantha J Mayo, K. Edelstein, E. Atenafu, Rand Ajaj +2 more
2024JAMA Network Open31 citations Open access
Semantic Scholar
The effectiveness of psychoeducational interventions on caregiver‐oriented outcomes in caregivers of adult cancer patients: A systematic review and meta‐analysis
G. Kusi, E. Atenafu, A. B. Boamah Mensah, Charlotte T. Lee +3 more
2022Psycho-Oncology30 citations
Semantic Scholar
TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation
Davidson Zhao, Mojgan Zarif, Qiang-Hua Zhou, Jose-Mario Capo-Chichi +5 more
2023Cancers27 citations Open access
Semantic Scholar
Dose-escalated two-fraction spine stereotactic body radiotherapy: 28 Gy vs. 24 Gy in 2 daily fractions.
Liang K. Zeng, A. Abugarib, H. Soliman, S. Myrehaug +10 more
2022International Journal of Radiation Oncology, Biology, Physics25 citations
Semantic Scholar
Dose Escalated Radiotherapy is Associated with Improved Outcomes for High Grade Meningioma.
Liang K. Zeng, H. Soliman, S. Myrehaug, C. Tseng +12 more
2023International Journal of Radiation Oncology, Biology, Physics24 citations
Semantic Scholar
Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local Control
A. Abugharib, Liang K. Zeng, C. Tseng, H. Soliman +9 more
2022Neurosurgery23 citations
Semantic Scholar
Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer.
Julian Chavarriaga, E. Atenafu, Ahmad Mousa, Carley Langleben +3 more
2024European Urology Oncology20 citations
Semantic Scholar
NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1.
Davidson Zhao, Mojgan Zarif, Entsar Eladl, Jose-Mario Capo-Chichi +6 more
2022Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis17 citations
Semantic Scholar
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation
M. Salas, E. Atenafu, I. Pašić, Ora Bascom +13 more
2023Bone Marrow Transplantation16 citations Open access
Semantic Scholar
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study
M. Perusini, I. Novitzky-Basso, E. Atenafu, D. Forrest +13 more
2023British Journal of Haematology15 citations
Semantic Scholar
Dose-dependent efficacy of bevacizumab in recurrent glioblastoma
Jawad M. Melhem, A. Tahir, Eirena Calabrese, I. Granovskaya +4 more
2023Journal of Neuro-Oncology15 citations Open access
Semantic Scholar
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis
J. Stewart, A. Sahgal, A. Chan, H. Soliman +15 more
2022Technology in Cancer Research and Treatment15 citations Open access
Semantic Scholar
Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis
Sonya T. Kim, C. Muñoz-Grajales, S. Dunn, R. Schneider +8 more
2023Arthritis Research & Therapy14 citations Open access
Semantic Scholar
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors
Peter J. Gariscsak, L. Anson-Cartwright, E. Atenafu, D. Jiang +7 more
2022European Urology Open Science14 citations Open access
Semantic Scholar
Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis
L. Whittall-Garcia, Kirubel Goliad, Michael Kim, D. Bonilla +6 more
2022Frontiers in Immunology14 citations Open access
Semantic Scholar
Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma.
S. Piedimonte, Ciara Murray, E. Atenafu, Marjan Rouzbahman +2 more
2024Gynecologic Oncology13 citations
Semantic Scholar
Different Immunologic Profiles Are Associated With Distinct Clinical Phenotypes in Longitudinally Observed Patients With Systemic Lupus Erythematosus
Kieran P. Manion, C. Muñoz-Grajales, Michael Kim, E. Atenafu +5 more
2023Arthritis & Rheumatology12 citations Open access
Semantic Scholar
A phase 2 study of a longitudinal multidimensional rehabilitation program for allogeneic blood and marrow transplantation patients
Samantha Tam, S. Alibhai, Dima Hassanieh, Rajat Kumar +8 more
2024Blood Advances6 citations Open access
Semantic Scholar
Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lymphoblastic leukaemia
Rui-Qi Chen, E. Atenafu, J. Seki, Xing Liu +8 more
2023British Journal of Haematology5 citations Open access
Semantic Scholar
Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study.
P. Remalante-Rayco, A. Espiritu, Yassir Daghistani, Tina Chim +7 more
2023Rheumatology5 citations
Semantic Scholar
Identifying Risk Factors and Outcome for CNS Involvement in AML.
J. Seki, Georgina S. Daher-Reyes, E. Atenafu, J. Sibai +10 more
2025Clinical Lymphoma, Myeloma & Leukemia4 citations
Semantic Scholar
Conditioning regimens for second allogeneic hematopoietic stem cell transplantation for patients with primary graft failure.
Nihar Desai, Sergio Rodriguez Rodriguez, Carol Chen, E. Atenafu +10 more
2025Transplantation and Cellular Therapy4 citations Open access
Semantic Scholar
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase
M. Perusini, C. Andrews, E. Atenafu, Vikas Gupta +11 more
2024Hematology4 citations Open access
Semantic Scholar
A longitudinal multidimensional rehabilitation program for patients undergoing allogeneic blood and marrow transplantation (CaRE-4-alloBMT): Protocol for a phase II feasibility pilot randomized controlled trial
Samantha Tam, Rajat Kumar, Paty Lopez, J. Mattsson +10 more
2023PLoS ONE4 citations Open access
Semantic Scholar
AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts.
Davidson Zhao, Qiang-Hua Zhou, Mojgan Zarif, Entsar Eladl +7 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis4 citations
Semantic Scholar
83: Dose-Escalated Two-Fraction Spine Stereotactic Body Radiotherapy: 28 GY Versus 24 GY in 2 Daily Fractions
Liang K. Zeng, A. Abugharib, H. Soliman, S. Myrehaug +8 more
2022Radiotherapy and Oncology4 citations
Semantic Scholar
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?
Sahar Khan, D. Reece, E. Atenafu, S. Bhella +7 more
2022Clinical Lymphoma, Myeloma & Leukemia4 citations
Semantic Scholar
Outcome of adolescents and young adult acute myeloid leukemia patients compared with middle-aged patients: A single centre retrospective experience.
Ruiqi Chen, M. Alhumaid, Georgina S. Daher-Reyes, E. Atenafu +8 more
2024Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis3 citations
Semantic Scholar
Outcomes of ATG-PTCY-CSA vs. ATG-based Prophylaxis for 10/10 HLA Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: ATG-PTCY-CsA for PB MUD allo-HCT.
Maria Queralt Salas, Tommy Alfaro-Moya, E. Atenafu, Arjun Datt Law +12 more
2024Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies
Tommy Alfaro Moya, M. Salas, Abel Santos Carreira, E. Atenafu +11 more
2024Bone Marrow Transplantation3 citations Open access
Semantic Scholar
High sensitivity c-reactive protein and circulating biomarkers of endothelial dysfunction in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Nazanin Aghel, Dakota Gustafson, D. Delgado, E. Atenafu +2 more
2023Leukemia and Lymphoma3 citations Open access
Semantic Scholar
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment
Rintu Sharma, E. Atenafu, E. Masih-Khan, H. Vohra +10 more
2026European Journal of Haematology2 citations Open access
Semantic Scholar
Real-world outcomes in adult histiocytosis: the uncharted territory of orphan diseases
Rintu Sharma, A. H. De La Torre, U. Falcone, E. Atenafu +5 more
2025Leukemia and Lymphoma2 citations
Semantic Scholar
Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection.
Julian Chavarriaga, Ahmad Mousa, E. Atenafu, L. Anson-Cartwright +3 more
2024Urologic oncology2 citations
Semantic Scholar
Long-term Relapse and Survival in Clinical Stage I Testicular Teratoma.
Julian Chavarriaga, Roderick Clark, E. Atenafu, L. Anson-Cartwright +8 more
2024European Urology Focus2 citations Open access
Semantic Scholar
Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia
S. Hershenfeld, E. Atenafu, S. Chan, Vikas Gupta +5 more
2023Acta Haematologica2 citations
Semantic Scholar
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR‐ABL negative myeloproliferative neoplasms
M. Davidson, F. Wong, M. Atri, H. Sibai +5 more
2023American journal of hematology/oncology2 citations Open access
Semantic Scholar
Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms
Dawn Maze, Iyad Arusi, V. Gupta, E. Atenafu +2 more
2022eJHaem2 citations Open access
Semantic Scholar
Factors influencing surgeons' decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery.
L. Hogen, Thirushi P. Siriwardena, Lina Salman, M. Bernardini +5 more
2025International Journal of Gynecological Cancer1 citations
Semantic Scholar
Updated analyses from a global meta-analysis in metastatic uveal melanoma (mUM) to determine progression free and overall survival benchmarks by line of therapy: An international rare cancers initiative (IRCI) ocular melanoma study.
L. Khoja, E. Atenafu, Anthony M. Joshua
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Eltrombopag in Treating Post‐Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering
Rawan Al-Omari, Ram Vasudevan Nampoothiri, Ali Sakhdari, E. Atenafu +9 more
2025European Journal of Haematology1 citations
Semantic Scholar
Who benefits from gilteritinib combination therapy amongst FLT3 mut R/R AML? Genomic insights.
A. Rajendra, Elliot Smith, M. Perusini, Kenny Tang +12 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis
A. Rajendra, Elliot Smith, M. Perusini, Kenny Tang +12 more
2025Blood Cancer Journal1 citations Open access
Semantic Scholar
PROPENSITY-MATCHED ANALYSIS OF OPEN VERSUS ROBOTIC PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION FOR CS II TESTICULAR CANCER
Julian Chavarriaga, Carley Langleben, L. Anson-Cartwright, M. Jewett +2 more
2024Urologic oncology: Seminars and original investigations1 citations
Semantic Scholar
Final Results of the Canadian Myeloma Research Group Trial of Cybord Induction, Double-Alkylator Conditioning with High-Dose Intravenous Busulfan + Melphalan, ASCT and Continuous Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (CMRG-001)
D. Reece, Giovanni Piza Rodriguez, Mariela Pantoja, E. Atenafu +14 more
2024Blood1 citations
Semantic Scholar
LONG-TERM OUTCOMES OF SURVEILLANCE OF CLINICAL STAGE I PURE TERATOMA OF THE TESTICLE
Julian Chavarriaga, L. Anson-Cartwright, Robert J. Hamilton, Roderick Clark +1 more
2024Urologic oncology: Seminars and original investigations1 citations
Semantic Scholar
Outcomes of Relapsed/Refractory Multiple Myeloma Patients Receiving Sequential Therapies after Exposure to T-Cell Redirected or BCMA-Targeted Novel Immunotherapies
Rintu Sharma, Pamella Paul, E. Masih-Khan, E. Atenafu +10 more
2024Blood1 citations
Semantic Scholar
Real-World Experience with CPX-351 for Secondary Acute Myeloid Leukemia: Comparison with FLAG-IDA in a Propensity Score Matching Analysis
M. Perusini, Claire Andrews, E. Atenafu, S. Assouline +17 more
2024Blood1 citations
Semantic Scholar
Impact of Kidney Dysfunction on Overall Survival in Myeloproliferative Neoplasms: A Single-Center Retrospective Study
Eshrak Al-Shaibani, T. Young, E. Atenafu, V. Cheung +6 more
2023Blood1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Dawn Maze×10
Invite
Dawn Maze — researcher profile on SciRah
H. Sibai×10
Invite
H. Sibai — researcher profile on SciRah
A. Viswabandya×6
Invite
A. Viswabandya — researcher profile on SciRah
A. Schuh×6
Invite
A. Schuh — researcher profile on SciRah

L. Anson-Cartwright

×6

Invite

L. Anson-Cartwright — researcher profile on SciRah

I. Novitzky-Basso×6

Invite

I. Novitzky-Basso — researcher profile on SciRah

Steven M. Chan×6

Invite

Steven M. Chan — researcher profile on SciRah

Invite

M. Minden — researcher profile on SciRah

Invite

Rajat Kumar — researcher profile on SciRah

Invite

H. Soliman — researcher profile on SciRah

Invite

S. Myrehaug — researcher profile on SciRah

Invite

J. Detsky — researcher profile on SciRah